Trial reportPhysiological reports2026
Effects of a glucosinolate-rich beverage on blood lactate concentrations during submaximal exercise.
Trial report in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sulforaphane Synergies with Phytochemicals and Pharmaceuticals: Implications for Healthspan.Medicines (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Glucosinolate-rich red kale sprouts (GRS) combined with intense exercise training for 7 days reduce blood lactate during exercise, attenuate hypoglycemic events, improve performance, and reduce markers of oxidative stress. This study aimed to investigate the acute, dose-dependent effects of GRS on blood lactate and blood glucose after ingestion of two different doses. In the study, healthy participants (n = 15) consumed 37.5 or 75 g of GRS or an isocaloric placebo blended into a beverage on three occasions. They cycled on an ergometer at three submaximal work rates (~100, ~120, ~140 W, respectively) before and 3 h after ingestion of GRS. Oxygen uptake, substrate-level oxidation, blood lactate, blood glucose, and ratings of perceived exertion were taken before and after each interval. GRS intake acutely decreased blood lactate during submaximal cycling and increased resting blood glucose. The largest lactate reduction occurred at 37.5 g compared to placebo, with concentrations 0.4 ± 0.6 mM lower at the highest work rate (p = 0.00175). For 75 g, the reduction was 0.3 ± 0.5 mM (p = 0.0484). No significant effects appeared at the lowest work rate. Resting blood glucose averaged 3.9 ± 0.3 mM after placebo compared to 4.3 ± 0.4 mM after 37.5 g and 4.3 ± 0.4 mM after 75 g GRS (p < 0.0001, respectively). In conclusion, these findings suggest that acute intake of a glucosinolate-rich beverage may influence lactate and glucose metabolism, with lower blood lactate concentrations observed at two submaximal work rates and altered blood glucose concentrations at rest.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.